| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/12/2007 | US7229619 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/12/2007 | US7229618 complex of Synagis light chain and N-terminal fragment of Synagis heavy chain; precipitated with polyethylene glycol from propanol solution; for screening for, identifying and/or designing compounds that bind and/or modulate a biological activity of respiratory syncytial virus |
| 06/12/2007 | US7229617 An isolated cell that expresses an antibody binding to DR4 or DR5, two members of the tumor necrosis factor (TNF) receptor super family |
| 06/12/2007 | US7229616 Gastrointestinal disorders; foods such as milk, ice cream, infant formula containing said lactobacillus |
| 06/12/2007 | CA2215834C Dna encoding human papillomavirus type 18 |
| 06/12/2007 | CA2214649C Antigen presenting system and methods for activation of t-cells |
| 06/12/2007 | CA2198251C Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| 06/12/2007 | CA2165157C Stable water-in-oil emulsions |
| 06/12/2007 | CA2130828C Non-azo naphthalimide dyes and uses for same |
| 06/12/2007 | CA2113712C Papilloma virus vaccine |
| 06/12/2007 | CA2076839C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
| 06/12/2007 | CA2072620C Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 06/12/2007 | CA2057828C Cytotoxic t lymphocyte-inducing lipopeptides and use as vaccines |
| 06/12/2007 | CA2046649C Matrix metalloproteinase inhibitor peptides |
| 06/09/2007 | CA2529677A1 Method of modulating gene transcription |
| 06/08/2007 | CA2539874A1 Novel uses of scleraxis |
| 06/07/2007 | WO2007065014A2 Methods and compositions to increase immune function |
| 06/07/2007 | WO2007064957A1 FCγ POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME |
| 06/07/2007 | WO2007064911A1 Anti-mouse cd20 antibodies and uses thereof |
| 06/07/2007 | WO2007064882A2 Treatment of conditions involving demyelination |
| 06/07/2007 | WO2007064844A2 Anti-viral griffithsin compounds, compositions, and methods of use |
| 06/07/2007 | WO2007064802A1 Chimeric viruses presenting non-native surface proteins and uses thereof |
| 06/07/2007 | WO2007064800A2 Methods to ameliorate and image angioplasty-induced vascular injury |
| 06/07/2007 | WO2007064757A1 Anti-thymocyte globulin to prevent or delay the onset or the progression on type 1 diabetes |
| 06/07/2007 | WO2007064742A2 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof |
| 06/07/2007 | WO2007064727A2 Penetrabodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases |
| 06/07/2007 | WO2007064696A2 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 06/07/2007 | WO2007063903A1 Novel peptide compound |
| 06/07/2007 | WO2007063539A1 Therapeutic uses of a3 adenosine receptor antibodies |
| 06/07/2007 | WO2007063311A2 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | WO2007063308A2 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | WO2007062851A2 Nucleic acids encoding tgev and prrsv sequences for improved expression of prrsv sequences |
| 06/07/2007 | WO2007062832A2 Vaccines containing non-live antigenic vectors |
| 06/07/2007 | WO2007062831A1 Vaccines |
| 06/07/2007 | WO2007062466A1 Demibodies: dimerisation-activated therapeutic agents |
| 06/07/2007 | WO2007048127A9 Fc labeling for immunostaining and immunotargeting |
| 06/07/2007 | WO2007041317A3 Immunomodulatory compositions and uses therefor |
| 06/07/2007 | WO2007039458A3 Hiv peptide conjugates and uses thereof |
| 06/07/2007 | WO2007031867A3 A hepatitis c virus non-stru tural ns3/4a fusion gene |
| 06/07/2007 | WO2007031550A3 Method for preparing immunoglobulin libraries |
| 06/07/2007 | WO2007030748A3 Methods and compositions for diagnosis and immunotherapy of pollen allergy |
| 06/07/2007 | WO2007024846A3 Anit-il-23 antibiodies |
| 06/07/2007 | WO2007023189A3 Pharmaceutical composition and its use for the prophylactic or therapeutic treatment of retroviral diseases |
| 06/07/2007 | WO2007018879A3 Interferon-gamma antagonists and therapeutic uses thereof |
| 06/07/2007 | WO2007011711A3 Paramyxoviridae virus preparations |
| 06/07/2007 | WO2007006573A3 Variant iaspp polypeptide and screening assay |
| 06/07/2007 | WO2007005627A3 Tuberculosis antigen detection assays and vaccines |
| 06/07/2007 | WO2006138514A3 Novel norovirus particle for use as an antiviral or vaccine |
| 06/07/2007 | WO2006137106A3 Method for the potentiation of opioid analgesics effects on pain |
| 06/07/2007 | WO2006135660A3 Therapies involving lymphotoxin beta receptor |
| 06/07/2007 | WO2006122123A3 Methods of alleviating disorders and their associated pain |
| 06/07/2007 | WO2006121895A3 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 06/07/2007 | WO2006121809A3 Inhibition of membrane fusion proteins |
| 06/07/2007 | WO2006108094A3 Organ homing genes of cancer metastases |
| 06/07/2007 | WO2006107924B1 Ehrlichia canis diva (differentiate infected from vaccinated animals) |
| 06/07/2007 | WO2006058202A3 Mer diagnostic and therapeutic agents |
| 06/07/2007 | WO2006002058A3 Treatment of autism |
| 06/07/2007 | WO2005060457A3 Treatment of inflammatory bowel diseases with anti-ip-10 antibodies |
| 06/07/2007 | US20070129366 Methods for the treatment of chronic pain and compositions therefor |
| 06/07/2007 | US20070129338 Hydroxy-1-azobenzene derivative for treatment of thrombocytopenia |
| 06/07/2007 | US20070129324 Mammalian MDM2 binding proteins and uses thereof |
| 06/07/2007 | US20070129322 Recombinant protective protein from Streptococcus pneumoniae |
| 06/07/2007 | US20070128721 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/07/2007 | US20070128703 An immobilized acceptor having at least two sugar units is contacted with Pasteurella multocida transferases selected from pmHAS, pmCS, pmHS, PglA, in a reaction medium with a sugar precursor selected from uridine diphosphate (UDP)-glucosamine, UDP-N-acetylglucosamine, or UDP-N-acetylgalactosamine |
| 06/07/2007 | US20070128701 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/07/2007 | US20070128695 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/07/2007 | US20070128692 Chimeric empty capsids of the infectious bursal disease viruse (ibdv), obtainment process and applications |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128616 Aggrecanase molecules |
| 06/07/2007 | US20070128600 Alpha macroglobulin family member |
| 06/07/2007 | US20070128586 Therapeutic, prophylactic and diagnostic agents |
| 06/07/2007 | US20070128230 Protein nmb0928 and use thereof in pharmaceutical formulations |
| 06/07/2007 | US20070128229 Surface proteins of Streptococcus pyogenes |
| 06/07/2007 | US20070128228 Buttock deformity treatment |
| 06/07/2007 | US20070128227 Multi-step therapy for injured muscles |
| 06/07/2007 | US20070128226 Methods of treating pain associated with abnormalities of the first metatarsophalangeal joint of the foot |
| 06/07/2007 | US20070128225 Immunogenic sequences |
| 06/07/2007 | US20070128224 nucleic acid molecules derived from its genome, the proteins and peptides encoded by the nucleic acid molecules, for use in medical diagnosis and/or as vaccines |
| 06/07/2007 | US20070128223 CD40 ligand fusion protein vaccine |
| 06/07/2007 | US20070128222 immunizing against infection of the respiratory tract caused by paramyxoviruses such as parainfluenza virus, with a viccine containing Venezuelan Equine Encephalitis virus replicase proteins, genes, and parainfluenzavirus F glycoprotein, genes; treating respiratory syncytial virus infection |
| 06/07/2007 | US20070128221 An immunoassay device comprising a solid substrate having attached a polypeptide consisting of SEQ ID NO:3; new antigenic regions of hepatitis C virus referred to as HCV-3 and HCV-4 identified and sequenced to providemore complete blood screening and genotyping; immunoassays; antibodies; vaccines |
| 06/07/2007 | US20070128220 Materials and methods relating to fusion proteins for inducing an immune response |
| 06/07/2007 | US20070128219 Molecular antigen arrays |
| 06/07/2007 | US20070128218 Diagnosis and treatment of hepatic disorders |
| 06/07/2007 | US20070128217 Antigenic peptides of SARS coronavirus and uses thereof |
| 06/07/2007 | US20070128216 Derived from recombinant attenuated intracellular pathogenic bacteria, specifically, attenuated Mycobacteria that over-express and secrete major extracellular proteins; useful in inducing immune responses in hosts |
| 06/07/2007 | US20070128215 Streptococcus phocae vaccine |
| 06/07/2007 | US20070128213 Novel plant virus particles and methods of inactivation thereof |
| 06/07/2007 | US20070128211 Surface proteins of Streptococcus pyogenes |
| 06/07/2007 | US20070128210 Surface proteins of Streptococcus pyogenes |
| 06/07/2007 | US20070128209 Vaccine based method for protection against hiv infection |
| 06/07/2007 | US20070128208 Method for the treatment of airway diseases |
| 06/07/2007 | US20070128207 Method of selecting wt1 vaccine adaptive patient |
| 06/07/2007 | US20070128206 enhancing antigenicity of a vaccine by administering a sugar cane-derived extract having a low saccharide concentration obtained by column chromatography; ion exchange resin; |
| 06/07/2007 | US20070128205 Cytokine protein family |
| 06/07/2007 | US20070128204 Methods and compositions for inducing apoptosis in cancer cells |
| 06/07/2007 | US20070128203 Anti-integrin antibodies, compositions, methods and uses |
| 06/07/2007 | US20070128202 inhibiting growth of cancerous cells using an antibody (mPA7) which binds to antigen CD46 which is present on a variety of human cancers from ovary, breast, lung, prostate, colon, kidney, and pancreas |
| 06/07/2007 | US20070128201 Combined use of ecteinascidin-743 and platinum antineoplastic compounds |
| 06/07/2007 | US20070128200 Thromboembolic disease, ischemic disease, venous thromboembolism, arterial or venous thrombosis, pulmonary embolism, restenosis, diabetic angiopathy and allograft atherosclerosis; peptides from the receptor binding region of human Growth Arrest Specific Gene 6 (Gas6) and antibodies |